The discovery that UCP2-deficient mice resist to Toxoplasma gondii infection, attributed to elevated ROS production in macrophages130, has brought renewed attention to UCP2’s role in modulating immune and metabolic responses, with important implications for cancer biology. Here, UCP2 is linked to cancer.